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This work describes a systematic approach to the accurate quantification 
of selenoproteins (SEPP1) in human plasma/serum by IDA-LC-ICP-MS 
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Abstract 
A species-specific isotope dilution analysis (SS IDA) method was developed for the first time 
for the determination of selenoprotein P (SEPP1) in human plasma/serum at the protein level 
by double affinity HPLC-ICP-MS. In this regard, a standard and a spike of SEPP1 were 
produced by cell-free E.coli protein synthesis, where Se (ICP tag) was introduced in the form 
of selenomethionine (SeMet) allowing for the absolute SEPP1 quantification by ICP-MS. A 
complete characterization of the standard and the spike was carried out in terms of isotopic 
composition and Se mass fraction by collision-cell ICP-MS to ensure SI-traceability. Method 
development and validation were conducted using the reference materials BCR-637, 
extensively analysed for its Se species, and the SRM 1950, which provides reference values 
for Se species (including SEPP1). Stability of the isotope ratio R77/76 in the sample blends 
was tested for one month with negligible change. Relative expanded uncertainties of 5.7% 
and 7.7% were achieved for BCR-637 and SRM 1950 for mass fractions of 55.5 and 63.9 ng 
g-1 Se for SEPP1, respectively. The developed SEPP1 SS IDA methodology could be a 
valuable tool to establish references values for selenoproteins in clinical chemistry and 
showed the potential of cell-free protein synthesis for the preparation of future stable isotope-
labeled intact selenoproteins. 
 
Key-words: selenoproteins, SEPP1, isotope dilution, ICP-MS, BCR-637, SRM 1950. 
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Introduction 
Selenium (Se) is an essential nutrient (recommended daily allowance of 55 µg/day) and trace 
element for human health1. The most common Se-species in food are the inorganic selenite 
and selenate as well as the Se-amino acids selenocysteine (SeCys) and selenomethionine 
(SeMet, the major dietary form). The health benefits of Se in humans come from its 
antioxidant properties, its involvement in the immune and endocrine system and its 
protection against certain disorders, in particular cancer2. Randomized controlled trials of Se 
supplementation for cancer prevention have yielded conflicting results, pointing out the 
complexity of Se metabolism due to the different toxicological and physiological properties of 
Se-species1,3 . Thus, a better understanding of Se speciation is required. The biological 
activity of Se is principally mediated by selenoproteins, where Se is genetically incorporated 
as SeCys. The human selenoproteome contains 25 known selenoproteins, and among these 
selenoprotein P (SEPP1) and plasma glutathione peroxidase (GPx3) are the most abundant 
Se-species in human plasma/serum. SEPP1, which accounts for about 50%, is responsible 
for Se transport and homeostasis, while GPx3 is an antioxidant enzyme which constitutes 
approximately 15-20% of total Se. The other main plasma/serum form of Se is Se-human 
serum albumin (Se-Albumin), a Se-containing protein, which occurs by the non-specific 
replacement of methionine with SeMet2. These three proteins (GPx3, SEPP1 and Se-
Albumin) are the most commonly used markers for the assessment of Se status in human 
plasma/serum. However, its accurate determination and method validation remains a difficult 
task because of the lack of speciated certified reference materials (CRMs), pure primary 
standards and reference methods.  
Isotope dilution mass spectrometry (IDMS) is recognised by the CCQM (Consultative 
Committee on Amount of Substance) as a primary measurement procedure4, i.e. a method 
which is completely described and understood, having the highest metrological qualities and 
for which the results can be given with a complete uncertainty statement. The combination of 
isotope dilution analysis (IDA) with ICP-MS can lead to results with the highest accuracy, 
precision and smallest combined uncertainty. Therefore, it is the method commonly used by 
most of the National Metrology Institutes (NMIs) for reference material (RM) certification or 
used as a reference method for elemental and speciation analysis5. IDA-ICP-MS has been 
used for the certification of the total Se content (64-133 ng g-1) in the following human 
serum/plasma RMs: BCR 637-9, ERM-DA120a and SRM 1950. This was rather easy to 
achieve due to the availability of commercially isotopically-enriched Se spikes (i.e. 74Se, 76Se, 
77Se, etc.). However, the accurate quantification of selenoproteins using hyphenated 
techniques (speciation approach) has been limited by the non-availability of commercially 
species-specific enriched intact selenoproteins. As an alternative, Jitaru et al.6 developed a 
species-specific (SS) IDA-ICP-MS approach at the amino-acid level for the determination of 
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Se-Albumin based on the enzymatic hydrolysis of the serum, in the presence of 76Se 
isotopically enriched in SeMet, and the quantification of the released SeMet by ion paring 
reversed-phase ICP-MS. However, SeMet quantification can be only correlated to an 
accurate Se-Albumin determination after proving the absence of free SeMet in the serum. On 
the other hand, it allows the simultaneous determination of SeCys7, but it is not able to 
distinguish between GPx3 and SEPP1, since both contain SeCys. Alternative quantification 
approaches at the protein level by on-line external calibration6, 8 - 10 , antibodies 11 , 12  and 
species-unspecific IDA-ICP-MS8,9,13-18 have been conducted in order to overcome the lack of 
pure Se-proteins standards and spikes. Among these quantification methods, the most 
accurate approach has been species-unspecific IDA-ICP-MS (also called post-column IDA), 
which allows the quantification of Se in Se-species when they are unknown or when Se-
protein standards are not available, by the post-column addition of isotopically enriched Se 
spikes (i.e. 77Se, 74Se). This methodology was used to provide reference values of GPx3, 
SEPP1 and Se-Albumin in the reference material SRM 1950 after the separation of Se-
species by double affinity HPLC14. Although quantitative Se recovery was proved, post-
column IDA is not considered a primary method of analysis and it does not account for any 
losses or transformation occurring during sample preparation or species separation. 
Moreover, metrological traceability needs to be assured by the accurate determination of the 
mass injected, the mass flow and the mass fraction of the spike19. 
In order to overcome these limitations, SS IDA approaches should be explored for the 
accurate determination of selenoproteins in human plasma/serum. In this regard, the aim of 
this work was the development of metrological methodologies based on the use of IDA in 
combination to LC-ICP-MS to ensure SI-traceability in Se speciation analysis. For this 
purpose, a SEPP1 SS IDA-ICP-MS approach was carried out for the first time by using a 
synthesized [Sec-to-Cys]SEPP1 stable isotope spike enriched in 76SeMet. Two human 
serum/plasma RMs were used for method development and accurate assessment: the BCR-
637, which is certified for total Se and widely analysed for its Se species by other authors, 
and the SRM 1950, which provides reference values for total Se and Se species. In order to 
achieve a complete mass balance of Se in these human plasma/serum RMs, the total Se 
content was determined by IDA-ICP-MS and Se species (GPx3, SEPP1 and Se-Albumin) 
were also quantified by post-column IDA. 
EXPERIMENTAL 
Reagents and Materials 
All reagents used were of at least analytical or high-purity grade. Ultrapure water of 18.2 
M.cm was obtained by means of a Milli-Q system (Millipore SAS, Molsheim, France). HPLC 
Mobile phases containing (A) 0.05 M and (B) 1.50 M ammonium acetate (Sigma-Aldrich, St. 
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Louis, MO, USA) were adjusted to pH 7 with acetic acid (Merck, Darmstadt, Germany) and 
filtered through 0.22 m (Sigma-Aldrich). Amicon Ultra 0.5 mL centrifugal filters of 3 and 30 
kDa cut-off were purchased from Sigma-Aldrich. Enriched 77Se (lot k2781) was obtained from 
Euriso-top (Saint-Aubin, France) as elemental powder (99.20%) and it was dissolved in a 
minimum volume of nitric acid suprapur® (HNO3, Merck) and further diluted with Milli-Q. For 
total Se analysis and Br/Se hydride corrections, a primary Se standard solution SRM 3149 
(NIST, Gaithersburg, Maryland, USA), a high purity Se metal (Alfa Aesar, Karlsruhe, 
Germany) and a certified standard solution of 1000 mg kg-1 of sodium bromide from Sigma-
Aldrich were used. Intermediate and working elemental solutions were prepared in 2% (v/v) 
HNO3 for direct ICP-MS measurements and in mobile phases for selenoproteins 
determination. SeMet (Sigma-Aldrich) and the RM SeMet enriched with 76SeMet (LGC7330) 
from LGC Standards (Teddington, UK) were used for the preparation of SEPP1 standard and 
SEPP1 spike, respectively. A nuclease-free water e.g. UltraPure DNase/RNase-Free 
distilled water (Life Technologies, Germany), the RTS 500 Proteomaster E.coli HY Kit 
(5PRIME, Germany) and the modified pEXP2– DEST Gateway Destination Vector (Thermo 
Scientific) as expression vector were used during the cell-free protein synthesis. 
The biological reference materials analysed in this work were: the human serum CRM BCR-
637 (Lot 744 and 974) from the Institute for Reference Materials and Measurements (IRMM, 
Geel, Belgium) and the human plasma SRM 1950 Metabolites in Human Plasma from NIST.  
Instrumentation 
Solutions were prepared gravimetrically in a class 10,000 cleanroom using calibrated 
analytical balances with 0.1 and 0.001 mg resolution (Sartorius AG, Goettingen, Germany). A 
densimeter (Anton Paar, Graz, Austria) was used to determine the density of the serum. 
Sample digestions were carried out with a microwave oven Discover SP-D (CEM Corporation, 
Matthews, USA). Serum was ultrafiltrated by using a centrifuge Eppendorf 5418 (Thermo 
Fisher Scientific, Hamburg, Germany). The cell-free synthesis was carried using a 
thermomixer equipped with an RTS 500 Adapter (5PRIME) and electro-elution from 
polyacrylamide gel was done using an electro-eluter model 422 from Bio-Rad. The molecular 
characterization of human recombinant SEPP1 standard and spike were conducted by ultra-
high performance liquid chromatography electrospray mass spectrometry (UPLC ESI 
MS/MS) using an EASY-nLC 1000 (Thermo Scientific) coupled to an Orbitrap Velos mass 
spectrometer (Thermo Scientific)22. Two PEEK chromatographic columns (5 cm x 4.6 mm 
i.d.) were packed with 1 mL affinity stationary phases of commercial columns (GE Healthcare, 
Uppsala, Sweden) named HiTrap® Heparin HP and HiTrap® Blue HP for selenoprotein 
separation. The columns were connected to a Spectra System P4000 HPLC system (Thermo 
Fisher Scientific Inc., MA, USA) and a 6-port 2-position microelectric valve (Valco 
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6 
Instruments Co. Inc., Texas, USA) for column switching. The post-column solution was 
introduced through a T-connector (Supelco, Bellefonte, PA, USA) using a peristaltic pump 
Minipuls 3 (Gilson, Villiers, France). The HPLC system was connected directly to the ICP-MS 
by using a PEEK tubing (0.50 mm i.d., Supelco). A Thermo Scientific iCAP Q ICP-MS 
(Thermo Fisher Scientific, Bremen, Germany) was used, operating in He-KED (kinetic energy 
discrimination) by using 1.5 mL min-1 He and 2.0 mL min-1 H2. Operational conditions and 
data acquisition parameters are given in Table 1. 
Procedures 
Total Selenium quantification by IDA-ICP-MS. For the determination of total Se by IDA, 
samples containing an appropriate amount of 77Se enriched spike were microwave digested 
in the presence of 2 g HNO3 and 3 g Milli-Q water, heated up to 200°C in 4 min and kept at 
this temperature for 3 min. The extracts were further diluted with 2% HNO3 and analysed in a 
quadrupole ICP-MS using a mixture of He and H2 to eliminate argon-based interferences. 
Signal intensities were corrected for Se hydration (SeH+) applying the mathematical 
equations previously described20  and detector dead time. The measured 78Se/77Se ratio 
(R78/77) was then corrected for mass bias using the linear model. Double IDA-ICP-MS was 
applied for the determination of Se in 4 independent sample blends from BCR-637 and SRM 
1950. The isotopic composition of the 77Se-enriched spike was determined by ICP-MS over 1 
year and its mass fraction was calculated daily by reverse-IDA against a pure Se standard 
using 4 calibration blends. Plasma conditions and acquisition parameters are reported in 
Table 1. 
Separation of selenoproteins by double affinity HPLC. The simultaneous fractionation of 
the selected selenoproteins (GPx3, SEPP1 and Se-Albumin) in human plasma/serum was 
carried out by double affinity chromatography (AF) HPLC using two custom-made columns of 
Heparin and Blue affinity resins, following the experimental setup described elsewhere9 and 
the chromatographic conditions of Table 1.  
Quantification of selenoproteins by double AF-HPLC-ICP-MS. Two IDA-LC-ICP-MS 
approaches, specially focused on SEPP1’s quantification, were investigated for the 
determination of selenoproteins in the human serum/plasma RMs BCR-637 and SRM 1950. 
Plasma conditions and acquisition parameters for AF-HPLC-ICP-MS are reported in Table 1. 
The chromatographic peaks were integrated using Origin 7.5 (v7.5853, Origin Lab 
Corporation, Northampton, MA, USA). 
Species-specific Isotope Dilution Analysis (SS IDA) for SEPP1. In order to perform SS IDA, a 
full-length human recombinant selenoprotein P (SEPP1_HUMAN; UniProt accession no. 
P49908) spike and standard were produced using the RTS 500 Proteomaster E.coli HY Kit 
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according to the protocol provided by manufacturer. As an expression vector the modified 
pEXP2–DEST Gateway Destination Vector containing coding sequence for 
SEEP1_HUMAN was applied. In the modified pEXP2–DEST vector all ten TGA codons 
present in the coding sequence for SEPP1_HUMAN, which in vivo are Sec codons, were 
mutated to TGT codons encoding canonical Cys using conventional molecular cloning 
methods. During cell-free protein E.coli synthesis, Se was introduced into the polypeptide 
chain in the form of SeMet or 76Se-Met for the preparation of the SEPP1 standard and spike, 
respectively. The cell-free synthesis was carried out for 24 h at 30 °C with shaking at 1000 
rpm. The standard and spike were further purified by polyacrylamide gel electrophoresis 
separation (SDS PAGE) in combination with electro-elution. A more detailed description 
about the synthesis and the purification can be found elsewhere21,22. 
The SEPP1 standard and spike were characterised in terms of their isotopic compositions by 
double AF-HPLC-ICP-MS using the acquisition parameters for isotopic composition (Table1) 
with an integration time of 0.04s per isotope. Furthermore, the quantification of the total Se 
content in the [Sec-to-Cys]SEPP1 spike was performed by reverse IDA using two 
approaches. First, 3 replicates of about 50 L of the spike were ultrafiltrated by a 30kDa cut-
off to eliminate possible non-retained species generated during the spike synthesis and the 
corresponding fractions were digested in the presence of HNO3. An appropriate amount of 
natural Se standard was added before the mineralisation and the Se quantification was 
performed by total IDA-ICP-MS. On the other hand, 5 aliquots of the untreated spike were 
injected in the chromatographic system, and the Se eluted in the SEPP1 fraction (5-10 min) 
was quantified using post-column IDA (see next section). For the determination of the Se 
content in the SEPP1 of the RMs by SS IDA, at least 3 sample blends (mixture of serum and 
spike) were prepared gravimetrically. After equilibration of the mixture during 2 hours at room 
temperature, a dilution step in buffer A was applied before the analysis by double AF-HPLC-
ICP-MS.  Each measurement batch included a procedural blank, a mass bias solution and 
three injections of the sample blend. The synthesized [Sec-to-Cys]SEPP1 standard 
containing natural Se abundances was used for SeH+ and mass bias correction at a mass 
fraction similar to the SEPP1 in the sample ( 50 ng g-1 Se). The isotope ratio R77/76 was 
calculated and corrected as previously described. 
Post-column Isotope Dilution Analysis. Secondly, a species-unspecific IDA methodology was 
performed for the quantification of intact selenoproteins using the principle previously 
described23. A 77Se-enriched spike (0.4 – 0.5 ng g-1 Se in Milli-Q) is added at a continuous 
flow (0.1 g min-1) at the end of the column, obtaining a stable 77Se signal. To correct for SeH+ 
and BrH+ interferences, standard solutions of Se and Br (100 ng g-1 and 1 mg g-1, 
respectively) prepared in phase A and B were introduced post-column instead of the 
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8 
enriched spike, before and after a day analysis. Then, the isotope ratio R76/77 was calculated 
and mass bias corrected.  
Uncertainty estimation. A complete uncertainty budget was made following GUM24. The 
combined standard uncertainty uc was calculated following the propagation law of 
uncertainties, without variable correlations. All uncertainty values are expanded uncertainties 
with a coverage factor of k=2. A dedicated software was used for the estimation of 
uncertainties (Wincert version 3.13.0311.0026, Implex, France, http://www.implex.fr).  
Results and discussion 
Determination of Se-bound SEEP1 in human plasma/serum by SS IDA down to the 
protein level 
The accurate determination of intact selenoproteins in human plasma/serum has been 
limited by the absence of speciated Se CRMs, pure standards and reference methods. In this 
regard, method validation has been often relied on the total Se determination of the serum 
assuming that all Se is bound to the proteins which are eluted from the chromatographic 
system (sum of all Se-species)8,14,15. Figure 1 summarizes the different quantitative 
approaches developed in this work to achieve an accurate determination of Se in human 
plasma/serum. Two RMs were used in this work: the BCR-637 and the SRM 1950. The BCR-
637, certified for total Se, has been widely used in the literature to assess selenoproteins 
concentration in human serum6,8-910,15,16 and the SRM 1950 provides reference values for 
total Se, GPx3, SEPP1 and Se-Albumin14.  
Total Se measurements (Figure 1.1) could give us preliminary information regarding the 
normal or deficient level of Se in humans1. However, to assess a complete Se status, 
speciation approaches (Figure 1.2) that allow an accurate determination of all Se-species in 
the serum should be used. At protein level (Figure 1.3), on-line external calibration6,8-910 and 
post-column IDA8,9,13-18 have been the mainly used quantification methodologies due to the 
lack of isotopically enriched Se-species required to apply SS IDA. Moreover, the latter 
methodologies do not fulfil the requirements of primary methods and therefore are not 
completely suitable for the certification of RMs. In order to overcome these limitations, a SS 
IDA methodology was developed and validated for the first time for the accurate 
quantification of the Se-bound SEPP1 at the protein level in human plasma/serum (Figure 
1.3a). In this regard, a full-length human recombinant and stable isotope-labeled intact 
selenoprotein was synthesized by cell-free E.coli protein synthesis21,22. Since this procedure 
currently does not allow expressing native selenoproteins, SeCys-free selenoprotein 
standards were synthesized by the replacement of the originally 10 SeCys-residues (Sec) by 
10 cysteines (Cys) by point mutations of nucleotide triplets coding Sec to triplets coding Cys 
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in the coding sequence for selenoprotein present in the expression vector used as a template 
for E.coli protein synthesis. The proteins obtained in this way are named [Sec-to-
Cys]selenoprotein  standards. Since these standards do not contain Sec, selenium can be 
introduced in the cell-free E.coli protein synthesis medium in the form of SeMet or stable 
isotope enriched SeMet (76SeMet) to generate SeMet-SEPP1 or 76SeMet-SEPP1 standards, 
respectively. During the protein standard synthesis, 4 SeMet residues are incorporated into 
[Sec-to-Cys]selenoprotein P standard stoichiometrically at the sites of canonical Met in the 
protein structure. The verification of successful exchange of all SeCys residues for Cys 
residues and the incorporation of SeMet in the amino acid sequence of [Sec-to-
Cys]selenoprotein P standard were carried out by ESI MS/MS after trypsin digestion22. Figure 
2 shows the MS/MS spectrum for one of the [Sec-to-Cys]SEPP1 peptides containing the 
exchanged Cys residue (C), as well as their corresponding experimental and theoretical 
isotopic patterns. 
The current presence of a Se tag in the form of SeMet/76SeMet allowed an absolute 
quantification of SEPP1 via Se-specific ICP-MS detection at the protein level. In this regard, 
the second step in the development of the SS IDA approach was the inorganic 
characterisation of synthesized [Sec-to-Cys]SEPP1 standards. Firstly, the natural and the 
stable isotope enriched standards were characterised in terms of isotopic composition by 
double AF-HPLC-ICP-MS. The isotopic enrichment of 76Se in the spike was (99.85 ± 0.05)%, 
(k=2), which agrees with the isotopic abundance of the 76SeMet spike used during the 
synthesis (Table 2). On the other hand, the natural isotopic abundances of Se in the non-
labeled [Sec-to-Cys]SEPP1 standard were confirmed (Table 2) and this standard was further 
used for mass bias correction. Secondly, the Se mass fraction in the spike was calculated by 
reverse IDA using two approaches: a) by an on-line quantification of the SEPP1 eluted from 
the double AF-HPLC system using post-column IDA and a 77Se spike, which gave a mass 
fraction of (409 ± 43) ng g-1 Se, (n=5, k=2) and b) by an off-line approach where the spike 
was purified by a 30kDa cut-off membrane and the corresponding fractions were mineralized 
and analyzed by IDA-ICP-MS. The Se mass fraction of the higher fraction was (409.0 ± 7.0) 
ng g-1 Se, (n=3, k=2), in good agreement with the post-column value and with lower 
uncertainties. On the other hand, no significant Se levels were found in the filtrate ((10.9 ± 
7.0) ng g-1 Se). For further confirmation, this lower fraction was injected into the HPLC 
system and no Se-bound to SEPP1 was detected.  
Once the stable isotope enriched spike was characterized, this material was applied for the 
quantification of SEPP1 in the RMs by single SS IDA-ICP-MS (Supplementary information, 
Equation S-1) at different days using different pre-packed AF columns. Five independent 
sample blends of BCR-637 (Lot 744 and Lot 974) were prepared the same day and analyzed 
on four different days.  Each sample blend was run in triplicate and the results from all 
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measurements (n=15) were combined yielding a Se mass fraction of (55.5 ± 3.2) ng g-1 Se 
(k=2) for SEPP1, with a relative expanded uncertainty of 5.7%. This value is in good 
agreement with the values previously reported in the literature8,9,15,16 and also with those 
obtained by post-column IDA in this work (Table 3). The synthesized [Sec-to-Cys]SEPP1 
standard was injected into the chromatographic system between each triplicate sample blend 
for the correction of SeH+, giving an average yield of (2.85 ± 0.36)% evaluated at 4 different 
days during 8 h of measurement. Also, the stability of the isotope ratio R77/76 (0.276 ± 0.009) 
in the sample blends was tested for one month with negligible change. Figure 2 shows a 
chromatogram obtained for a sample blend of BCR-637 at masses 76 and 77, demonstrating 
the same behaviour of the naturally present SEEP1 in the serum and the stable isotope 
enriched SEPP1 spike.  
A complete uncertainty budget was elaborated according to the ISO/GUM guide24. The 
parameters taken into account for the calculation of the expanded uncertainty derived from 
the SS IDA-ICP-MS equation (Supplementary information, Equation S-1), including the 
measurement precision of the method. This last analytical parameter took into account the 
inter- and intra-day variability, the serum interbatch variability and the use of different home-
packed affinity columns. The intra-day variability was calculated as the relative standard 
deviation (RSD) of R77/76 of a duplicate sample blend, either the same blend or different 
blends, on a single day. Meanwhile the inter-day variability was evaluated based on the 
results of the sample blends on 4 different days over a period of one month. The intra-day 
variability, ranged from 0.2% to 2.8%, pointed out that variations within a single batch were 
similar than ones between different batches. On the other hand, a similar inter-day variability 
was obtained (0.3% - 3.2%), which showed no significant effect on the sample interbatch 
variability, the sample preparation and the use of different affinity columns. Considering the 
laboratory repeatability or intra-day variability, the most significant variables in the uncertainty 
budget for the determination of SEPP1 using single SSIDA are a) the measured isotope ratio
 
of the sample blend (60%), b) the Se mass fraction of the spike (17%), c) the mass of the 
spike (14%) and d) the mass bias correction factor, k (8%). As can be seen, the predominant 
sources of uncertainty are linked to the measurement of transient signals accounting for 
around 68% of the overall uncertainty, i.e. R77/76 in the sample blend and R77/76 in the 
calibration standard for mass bias correction (k). Taking into account the measurement 
precision, which combines inter- and intra-day variabilities, a relative expanded uncertainty of 
5.7% was obtained.  
A similar analytical approach was conducted for SRM 1950. In this particular case, three 
independent sample blends were prepared and run in four different days (n=12). The 
measured isotope ratio R77/76 (0.351 ± 0.013) in the sample blends kept also stable during the 
time analysis. The obtained intra- and inter-day variabilities, ranged from 0.2% to 4.5%, were 
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slightly higher in comparison to BCR 637. This could be ascribed to the nature of the sample, 
since plasma represents a more complex specimen than serum.  The mass fraction of 
SEEP1 (as Se) in the SRM 1950 was found to be (63.9 ± 4.9) ng g-1 Se (k=2) with a relative 
expanded uncertainty of 7.7%. A breakdown of the uncertainty budget showed the same 
contributing factors described above. However, in this case, due to a higher sample 
complexity, the measured isotope ratios in the sample blend and in the calibration standard 
accounted for about 75% and 10% of the total uncertainty budget, respectively.   
A slightly higher value for Se (as SEPP1) was obtained by SS IDA-ICP-MS in comparison to 
the reference value assigned by post-column IDA ((50.2 ± 4.3) ng g-1 Se, k=2.6)14. Although 
the species-unspecific approach is known to provide accurate quantification results23, it is 
unable to correct for possible Se losses during the analytical procedure. Furthermore, SS 
IDA-ICP-MS provided low uncertainties (5.7% and 7.7% for BCR-637 and SRM 1950, 
respectively), which could be used to establish reference values to clinical trials and in the 
characterization/validation of the calibration standard used in the ELISA kits for SEPP1. This 
enhancement on the SI-traceability of the immunoassays standards will allow data 
comparability in the determination of SEPP1 in serum/plasma. 
These data were further confirmed and validated with values obtained under the frame of the 
EURAMET EMRP « Metrology for metalloproteins » project where a new double SS IDA-
ICP-MS was developed based on the use of unique stable isotope enriched Se-peptides of 
SEPP1 (Figure 1.4a)25. Se mass fractions for SEPP1 of (56.2 ± 1.7) ng g-1 Se and (60.6 ± 
3.2) ng g-1 Se (k=2) in BCR-637 and SRM 1950, respectively, were obtained at the peptide 
level, which agree well with those obtained for the whole protein using single SS IDA-ICP-
MS. 
Selenium mass balance as quality control 
In order to evaluate Se mass balance from the double AF-HPLC-ICP-MS system to provide 
literature data comparison in the RMs BCR 637 and SRM 1950, total Se content by IDA-ICP-
MS (Figure 1.1) and Se-species quantification by post-column IDA were also explored 
(Figure 1.3c). The simultaneous determination of Se-species in the RMs was carried out by 
double AF-HPLC coupled to ICP-MS using Heparin and Blue stationary phases obtaining 
three chromatographic peaks. The first fraction labelled as “GP3x + non-retained species” 
represents all Se-species, mainly GP3x8, with no affinity to these resins, while Se-bound to 
SEPP1 and Se-Albumin are given in the second and third fraction, respectively. Se mass 
balance in the double AF-HPLC-ICP-MS will be estimated by the sum of Se mass fractions 
from the three chromatographic fractions divided by the total Se obtained by IDA-ICP-MS. 
a) Total Se content in human plasma/serum by double IDA-ICP-MS. The second 
step of our validation approach was the determination of total Se by double IDA-ICP-MS 
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(Figure 1.1). The BCR-637 value obtained for the measured R78/77 (79.6 ± 1.6) ng g-1 Se 
(k=2, n=4) fits perfectly with the reference value (79 ± 7) ng g-1 Se (k=2), which was 
expressed as mass fraction taking into account its measured density (1.0237 ± 0.0044) g mL-
1
 (k=2). A normalised error (EN) of 0.14 lower than 2 proves that there are no significant 
differences between the determined and the certified value. For the SRM 1950, a Se mass 
fraction of (96.9 ± 4.1) ng g-1 Se (k=2, n=4) was determined by double IDA-ICP-MS, which is 
also in agreement with the reference value (105.5 ± 3.8) ng g-1 Se (k=2.2, R80/77) with an EN 
of 1.50. The R78/77 ratio was preferred to R80/77 to avoid further corrections due to the BrH+ 
interference on the 80Se signal20. 
b) Se-species determination in human plasma/serum by post-column IDA-ICP-MS. The 
post-column IDA methodology has been widely used to assign Se-species values in BCR 
human RMs,,15,16, in quality control materials16, in human populations13,15,17,18 and in SRM 
195014. Until now, due to the lack of speciated selenoprotein standards, this has been the 
most accurate quantification method for selenoproteins. However, several variables involved 
in the on-line equation (Supplementary information, Equation S-2) should be carefully 
determined to ensure accurate and SI traceable results. In this regard, the flow of the spike 
was gravimetrically calibrated at the beginning and at the end of each day ((0.11005 ± 
0.00091) g min-1), its Se mass fraction was determined daily by reverse IDA-ICP-MS ((0.504 
± 0.017) ng g-1 Se) and the loop was gravimetrically calibrated to obtain the mass injected 
((0.0495 ± 0.0096) g). Seven replicates from 2 different lots of BCR-637 (Lot 744 and 974) 
were systematically analysed at 2 different days using 2 different home-packed AF columns 
in order to account for interbatch Se variability and column loading.  Similarly, for SRM 1950, 
11 replicates were analysed at 3 different days using 2 different pre-packed AF columns. A 
summary of the quantification results for BCR-637 and SRM 1950 using the post-column IDA 
methodology is presented in Table 3, as well as values for BCR-637 reported in the literature 
based on the same approach,15,16. Regarding BCR-637, the developed post-column 
approach gave results for all three Se-species in close agreement with those already 
reported and a total Se recovery from the AF-HPLC system was achieved ((100 ± 7)%). 
Expanded uncertainties between 12% and 16% were obtained for all selenoproteins (k=2), 
where the main contribution to the uncertainty budget was the measured isotope R76/77 in the 
mixture (60-89%). Other parameters that should be considered are the Se mass fraction of 
the spike (4-17%) and the mass injected (6-22%). Also in this case, no significant differences 
within experimental uncertainties were found by using different AF columns. 
In case of SRM 1950, a good agreement between experimental and reference values14 was 
obtained by post-column IDA considering expanded uncertainties for the individual and the 
sum of Se species, except for the first fraction (GPx3 + non-retained species). A lower Se 
mass fraction (R76/77) was obtained in comparison to the reference value using the ratio 
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R80/77. This higher value could be related to the interference of 79BrH+ on the 80Se isotope. It 
was proved that the presence of 1 µg g-1 Br caused a bias of about 56% in the 77Se/80Se ratio 
in a solution of 20 ng g-1 of Se20. Nevertheless, a Se mass balance of (102 ± 10)%) was 
achieved for SRM 1950, which showed a complete Se chromatographic recovery. Expanded 
uncertainties between 11% and 16% were obtained for selenoproteins, similar to those 
obtained for BCR-637. Also here, the main contributions to the uncertainty budget were the 
measured isotope R76/77 in the mixture (79-89%), the Se mass fraction of the spike (4-9%) 
and the mass injected (6-11%). The main advantage of the post-column approach is that it 
allows the quantification of all possible Se species even if they are unknown and that it does 
not require any sample pre-treatment. On the other hand, losses before the complete mixing 
of sample and spike are not corrected for and post-column IDA provides higher uncertainties 
in comparison to SS IDA-ICP-MS (8.2% vs 5.7% for BCR-637 and 12.1% vs 7.7% for SRM 
1950 in the case of SEPP1). Furthermore, a careful control of all experimental parameters 
associated with the post-column equation should be conducted; while a small impact (<1%) 
in the total uncertainty budget was observed for the spike’s flow, the mass injected 
contributed between 4% to 22%. 
 
Conclusions 
The present work illustrates the development of potential reference measurement 
procedures of high metrological order based on the combination of IDA and ICP-MS for the 
accurate assessment of Se in human serum. Here, a SEPP1 SS IDA at the protein level was 
developed for the first time by the use of a stable isotope enriched standard ([Sec-
toCys]SEPP1). After the complete characterisation of the spike (for isotopic composition and 
Se mass fraction), SEPP1 was determined in the RMs BCR-637 and SRM 1950. Results 
obtained were in good agreement with those achieved by SS IDA via Se-peptides25 and by 
post-column IDA. However, SS IDA-ICP-MS provided the smallest uncertainties and seems 
less affected by Se interbatch variability, affinity column capacity and possible analyte losses. 
On the other hand, post-column IDA is a quantitative approach easier to be implemented and 
less time consuming, which allowed the simultaneously determination of Se-species in 
human serum/plasma RMs.  
The developed SEPP1 SS IDA methodology could be used for the validation and quality 
assurance of routine assays and for the certification of RMs, which will ensure SI traceability 
in Se speciation. Moreover, this work reveals the excellent capabilities of cell-free E.coli 
protein synthesis for the production of other stable isotope labeled standards that can be 
extended to other selenoproteins (e.g. GPx3, thioredoxin reductase)22. 
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Tables 
 
 
 
Table 1. Operating conditions for the separation and quantification of selenoproteins in 
human plasma/serum  
Double AF-HPLC conditions 
Affinity columns 
 
Binding Buffer (A) 
Elution Buffer (B) 
Injection volume 
Flow rate 
Gradient 
 
 
 
iCAP Q ICP-Q-MS parameters  
RF Power 
Carrier gas flow 
Auxiliary gas flow 
He gas flow 
H2 gas flow 
Collision cell Bias 
Pole Bias 
Total Se analysisc 
Monitored masses for IDA 
Monitored masses for isotopic composition 
Replicates 
Time resolved analysis (TRA) 
Species-specific IDA 
Post-column IDA 
 
 
a
 Masses measured for IDA 
b
 Masses measured for corrections 
c
 Integration time is given in brackets 
 
HiTrap Heparin Sepharose (5 cm x 4.6 mm id)  
HiTrap Blue Sepharose (5 cm x 4.6 mm id)  
0.05 mol L-1 Ammonium Acetate, pH 7 
1.50 mol L-1 Ammonium Acetate, pH 7 
50 L (0.0495 ± 0.0096) g, k=2 
1 mL min-1  
0-5 min, Buffer A, Position P1 (load)  
5-10 min, Buffer B, Position P2 (inject)  
10-15 min, Buffer B, Position P1 
 
 
1550 W 
1.05 L min-1 
0.80 L min-1 
1.50 mL min-1 
2.00 mL min-1 
-21 V 
-18 V 
 
76, 77, 78 (1s)a; 82, 83 (0.4s)b 
74, 76, 77, 78, 80, 82, 83 (0.4s) 
5 
 
76, 77, 78 (0.1s)a; 82, 83 (0.04s)b 
76, 77, 78 (0.1s)a 
76, 77, 78, 79, 80, 81, 82, 83 (0.04s)b 
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Table 2. Isotopic composition of the synthesized [Sec-to-Cys]SEPP1 spike and 
standard by double AF-HPLC-ICP-MS 
 
Abundance, % (n=4, k=2) 
Se Isotopes  Spike  Standard 
74Se 0.035 ± 0.005 0.69 ± 0.02 
76Se 99.85 ± 0.05a 7.7 ± 0.3 
77Se 0.05 ± 0.06 6.5 ± 0.3 
78Se 0.03 ± 0.02 21.3 ± 0.9 
80Se 0.02 ± 0.03 54.5 ± 2.0 
82Se 0.011 ± 0.008 9.3 ± 0.4 
Atomic weight, g mol-1 75.92 ± 0.13 78.96 ± 0.03 
a
 
76Se isotopic abundance of SeMet enriched with 76Se (RM LGC 7330): 99.8(0.2)% 
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Table 3. Selenium mass fractions (ng g-1 Se) determined in BCR-637 and SRM 1950 by post-
column IDA-ICP-MS 
 
Se-species 
BCR-637 SRM 1950 
This study   [15]a [16] [9]a This study   
(n=7, k=2) (n=27) (n=5) (n=3) (n=11, k=2) 
GPx3 + non-retained species 11.1 ± 1.5 16 ± 3 11 ± 1 13 ± 1 15.1 ± 1.7 
SEPP1 52.7 ± 4.3 51 ± 5 52 ± 2 64 ± 5 61.1 ± 7.4 
Se-Albumin 15.8 ± 2.5 9 ± 2 17 ± 2 14 ± 1 23.1 ± 3.7 
Sum of species 80 ± 5 75 ± 9 80 ± 2 90 ± 5 99 ± 8 
Total Se 79 ± 7 (k=2)a 105.5 ± 3.8 (k=2.2) 
a
 Reported values have been converted into ng g-1 Se using the density for data comparison 
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Figures 
 
 
 
 
Figure 1. Workflow for the accurate assessment of selenoproteins in human serum  
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Figure 2. Molecular verification of the exchanged Cys residue (C) for the [Sec-to-Cys]SEPP1 
peptide ENLPSLCSCQGLR by ESI MS/MS. (a) MS/MS spectrum, (b) experimental and (c) 
theoretical isotope pattern. U=SeCys  
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Figure 3. A sample blend (mixture of BCR-637 and the stable isotope enriched SEPP1 
spike) chromatogram obtained by AF-HPLC-ICPMS  
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Equation S-1. Model equation for species-specific IDA-ICP-MS for SEPP1 
 
 
Equation S-2. Model equation for species-unspecific IDA-ICP-MS 
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Equation S-1. Model equation for species-specific IDA-ICP-MS for SEPP1 
The equation used for the determination of SEPP1 mass fraction (expressed as Se) in 
human plasma/serum by species-specific IDA-ICP-MS is shown below: 
 
 sBAs
spspBA
sp
s
s
sp
sps BkRA
ABkR
W
W
m
m
ww



/
/
      Equation 1 
 
ws, mass fraction of SEPP1 in the sample blend (ng g-1 Se) 
wsp, mass fraction of SEPP1 in the spike (ng g-1 Se): (47.2 ± 1.0) ng g-1 Se, k=2 
ms, mass of the sample in the sample blend (g): (0.10487 ± 0.00051) g, k=2 
msp, mass of the spike in the sample blend (g): (0.02567 ± 0.00051) g, k=2 
Ws, atomic weight of the sample (g mol-1): (78.96 ± 0.03) g mol-1, IUPAC value, k=2 
Wsp, atomic weight of the spike (g mol-1): (75.92 ± 0.13) g mol-1, k=2 
RA/B, isotope ratio measured in the mixture: R77/76 
k, mass bias correction factor: (0.8407 ± 0.0088), k=2 
As, abundance of isotope A in the sample: (7.635 ± 0.010) %, IUPAC value 
Bs, abundance of isotope B in the sample: (9.366 ± 0.018) %, IUPAC value 
Asp, abundance of isotope A in the spike: (0.03 ± 0.02 %, k=2) 
Bsp, abundance of isotope B in the spike: (99.85 ± 0.05 %, k=2) 
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Equation S-2. Model equation for species-unspecific IDA-ICP-MS  
The on-line equation used for the determination of the Se mass fraction bound to intact 
selenoproteins (GPx3, SEPP1 and Se-Albumin) in human serum by post-column IDA-AF-
HPLC-ICP-MS is shown below: 
)(
)(
/
/
sBAs
spspBA
sp
s
spspsample BkRA
ABkR
W
WfwMF


      Equation 2 
 
MFsample, mass flow of the Se (ng Se) 
wsp, mass fraction of the Se  in the spike solution (ng g-1 Se): (0.504 ± 0.017) ng g-1 Se, k=2 
fsp, flow of the spike solution (g min-1): (0.11005 ± 0.00091) g min-1, k=1 
Ws, atomic weight of the sample (g mol-1): (78.96 ± 0.03) g mol-1, IUPAC value, k=2 
Wsp, atomic weight of the spike (g mol-1): (76.92 ± 0.03) g mol-1, k=2 
RA/B, isotope ratio measured in the mixture: R76/77 
k, mass bias correction factor: (1.0431 ± 0.0078), k=1 
As, abundance of isotope A in the sample: (9.366 ± 0.018) %, IUPAC value 
Bs, abundance of isotope B in the sample: (7.635 ± 0.010) %, IUPAC value 
Asp, abundance of isotope A in the spike: (0.051 ± 0.004) %, k=2 
Bsp, abundance of isotope B in the spike: (99.80 ± 0.25) %, k=2 
 
The mass fraction of Se (wsample, ng g-1 Se) in the sample was obtained by the integration of 
the peak area divided by the mass injected (g). The resulted mass fraction can be multiplied 
by the density of the serum (g mL-1) to get the Se concentration (ng mL-1) in each 
chromatographic peak.  
 
injected
sample
m
Area
w 
 
or 
 
sample
injected
sample
m
AreaC .
    
Equation 3 
 
Csample, concentration of Se in the sample (ng mL-1 Se) 
minjected, mass injected (g): (0.0495 ± 0.0096) g, k=2 
sample, density of BCR-637 RM (g mL-1): (1.0237 ± 0.0044) g mL-1, k=2 
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Figure 1. Workflow for the accurate assessment of selenoproteins in human serum 
Figure 3. A sample blend (mixture of BCR-637 and the stable isotope enriched 
SEPP1 spike) chromatogram obtained by AF-HPLC-ICPMS 
Figure 2. Molecular verification of the exchanged Cys residue (C) for the [Sec-to-
Cys]SEPP1 peptide ENLPSLCSCQGLR by ESI MS/MS. (a) MS/MS spectrum, (b) 
experimental and (c) theoretical isotope pattern. U=SeCys 
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Selenium Determination 
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1.Total Se by double 
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Analysis 
3. Intact selenoproteins 
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•Analytes: GPx3, SEPP1, Se-
Albumin, Sum of Se-species 
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determination 
3a. SEPP1 single 
SS IDA 
•Analyte: SEPP1 
•[Sec-to-Cys]SEPP1 standards, 
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4a. SEPP1 double 
SS IDA (peptide-
level)25 
•Analyte: SEPP1 
•Natural and 76SeCys Se-peptides, 
primary Se standard 
Figure 1. Workflow for the accurate assessment of selenoproteins in human serum. 
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Figure 2. Molecular verification of the exchanged Cys residue (C) for the [Sec-to-
Cys]SEPP1 peptide ENLPSLCSCQGLR by ESI MS/MS. (a) MS/MS spectrum, (b) 
experimental and (c) theoretical isotope pattern. U=SeCys 
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Figure 3. A sample blend (mixture of BCR-637 and the stable isotope enriched 
SEPP1 spike) chromatogram obtained by AF-HPLC-ICPMS 
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